|
|
|
| Clinical effect of Shuqing Pills in treating residual jaundice of liver diseases |
| KANG Yanyan WANG Yunqi LI Zhaohui GENG Lanshu LI Chengyu SU Guoquan SHEN Lixian |
| Department of Hepatology, Hebei TCM Liver Disease Hospital, Hebei Provence, Shijiazhuang 050800, China |
|
|
|
Abstract Objective To observe the clinical effect of Shuqing Pills in treating residual jaundice of liver disease. Methods From March 2015 to March 2017, 100 patients diagnosed residual jaundice of liver disease in Hebei TCM Liver Disease Hospital were selected, they were randomly divided into two groups, with 50 cases in the treatment group (including 41 cases of hepatitis, 9 cases of liver cirrhosis) and 50 cases in the control group (including 38 cases of hepatitis, 12 cases of liver cirrhosis). The treatment group was treated with Shuqing Pills, the control group was treated with Yinzhihuang Granules. 30 days is one course of treatment, 1-2 courses of treatment according to the disease. The total bilirubin levels were observed before and after treatment, the total effective rate of the two groups were compared, Meanwhile, adverse reactions during the treatment were monitored. Results After treatment, the total bilirubin levels of the two groups were decreased (P < 0.05); sixty days after treatment, the total bilirubin level of the treatment group was lower than that of the control group (P < 0.05). The total effective rate of the treatment group was better than that of the control group (P < 0.05). The total effective comparison in the subgroups: the rates of the cirrhosis subgroup and the hepatitis subgroup in the treatment group were better than those in the control group respectively (P < 0.05); besides, the rates of the hepatitis subgroup were better than those of the cirrhosis subgroup in the same group (P < 0.05). In the treatment group, two patients experienced mild gastrointestinal distress, and the gastrointestinal symptoms were relieved after discontinuation, and no other serious adverse reactions were observed. Conclusion Shuqing Pills can significantly reduce the level of bilirubin in patients with residual jaundice of liver disease, and less adverse reactions, which is worthy of clinical application.
|
|
|
|
|
|
[1] 韦明，李宏，郑帮林.苯巴比妥联合胆宁片治疗肝硬化残留黄疸的疗效观察[J].山西医药杂志，2012，41（9）：919-920.
[2] 王艳，孙梅花，田秀菊.苯巴比妥钠治疗病毒性肝炎残留黄疸临床观察[J].河北医药，2010，32（22）：3115-3115.
[3] 刘春文，杨沛华，蔡志诚，等.复方丹参滴丸联合熊去氧胆酸片治疗残留黄疸的成本效益分析[J].中国医药指南，2013，1（2）：574-576.
[4] 田红平.大黄蟅虫丸治疗残留黄疸临床观察[J].湖北中医杂志，2009，31（10）：40.
[5] 国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社，1994.
[6] 成军.肝脏病和感染病诊疗指南2009[M].北京：中华医学电子音像出版社，2009.
[7] 邹水泉，刘朝霞，尹燕耀，等.扶正祛瘀化痰退黄汤治疗乙型肝炎患者残留黄疸的疗效评价[J].当代医学，2017， 23（1）：118-119.
[8] 房英杰.自拟沙石退黄汤治疗慢性重型肝炎后残留黄疸疗效观察[J].中国中医急症，2012，21（4）：670-671.
[9] 陈大环.健脾益肾方治疗肝病后期残留黄疸的疗效观察及护理体会[J].湖南中医杂志，2012，28（1）：69-70.
[10] 罗最容.益气养肝退黄汤联合西药治疗乙肝肝硬化残留黄疸的疗效观察[J].中国社区医师，2016，32（36）：94-95.
[11] 黄运通，祁开安，林溢涛，等.健脾化湿祛瘀法治疗慢性乙型肝炎患者残留黄疸的临床疗效分析[J].中国实用医药，2016，11（30）：221-222. |
|
|
|
